ARNUITY ELLIPTA

This brand name is authorized in Australia, Canada, Japan, New Zealand, Singapore, United States

Active ingredients

The drug ARNUITY ELLIPTA contains one active pharmaceutical ingredient (API):

1	Fluticasone furoate UNII JS86977WNV - FLUTICASONE FUROATE
	Fluticasone furoate is a synthetic trifluorinated corticosteroid that possesses a very high affinity for the glucocorticoid receptor and has a potent anti-inflammatory action.
	Read more about Fluticasone furoate

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ARNUITY ELLIPTA Inhalation powder	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R03BA09		R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BA Glucocorticoids
Discover more medicines within R03BA09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11719T, 11729H
CA	Health Products and Food Branch	02446561, 02446588
JP	医薬品医療機器総合機構	2290705G1029, 2290705G2025
NZ	Medicines and Medical Devices Safety Authority	18044, 18045
SG	Health Sciences Authority	15021P, 15022P
US	FDA, National Drug Code	0173-0874, 0173-0876, 0173-0888